Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Jet Injection Devices for the Needle-free Administration of Compounds, Vaccines, and Other Agents

Author(s):  Logomasini Mark A, Stout Richard R, Ron Marcinkoski

Issue:  Jul/Aug 2013 - Volume 17, Number 4
View All Articles in Issue

Page(s):  270-280

Jet Injection Devices for the Needle-free Administration of Compounds, Vaccines, and Other Agents Page 1
Jet Injection Devices for the Needle-free Administration of Compounds, Vaccines, and Other Agents Page 2
Jet Injection Devices for the Needle-free Administration of Compounds, Vaccines, and Other Agents Page 3
Jet Injection Devices for the Needle-free Administration of Compounds, Vaccines, and Other Agents Page 4
Jet Injection Devices for the Needle-free Administration of Compounds, Vaccines, and Other Agents Page 5
Jet Injection Devices for the Needle-free Administration of Compounds, Vaccines, and Other Agents Page 6
Jet Injection Devices for the Needle-free Administration of Compounds, Vaccines, and Other Agents Page 7
Jet Injection Devices for the Needle-free Administration of Compounds, Vaccines, and Other Agents Page 8
Jet Injection Devices for the Needle-free Administration of Compounds, Vaccines, and Other Agents Page 9
Jet Injection Devices for the Needle-free Administration of Compounds, Vaccines, and Other Agents Page 10
Jet Injection Devices for the Needle-free Administration of Compounds, Vaccines, and Other Agents Page 11

Download in electronic PDF format for $75

Abstract:  Jet injection involves the use of a needle-free device that delivers a prescribed drug, vaccine, or compound intradermally, subcutaneously, or intramuscularly via high pressure produced by either a carbon-dioxide–filled or nitrogen-filled cartridge or a spring. During that procedure, the injector is held at an angle against the patient’s skin, and a very fine stream of liquid medication is forced through a tiny orifice in the device, penetrates the skin in a selected volume ranging from 0.05 mL to 1.0 mL, and is deposited in the underlying tissue. When compared with methods of injection that require a needle, jet injection offers multiple benefits. It can be less painful for the patient, and it enhances compliance, reduces risks such as needlestick injuries and cross-contamination, eliminates the need for “sharps” disposal, and enables (with minimal training) the reliable, reproducible, and accurate delivery of medication. Patient convenience is also a factor: Jet injectors are designed for self-medication as well as professional use. It must be remembered, however, that treatment via jet injection is not always painless. Because of their formulations, some medications and vaccines produce a burning or stinging sensation, whether they are administered with a jet injector or a needle. Some compounded preparations, like the formulations included in this article, can be administered by jet injection, a practice that we suggest will increase in popularity as more drugs are prescribed for administration in the home setting. Because changes in drug concentration may be required to effect the transfer of an agent or ensure the accurate reconstitution of a lyophilized drug administered with a jet injector, the skill of a compounding pharmacist will be essential in preparing customized injectates. In this article, we address the use of needle-free technology in general; present examples of carbon-dioxide, spring-powered, and novel jet injection systems; and answer questions of interest to compounders about the use of jet injectors.

Related Keywords: jet injection, needle-free injection technology, NFIT, formulations, intradermal administration, subcutaneous administration, intramuscular administration, injectates, patient compliance, product information, drug delivery, FAQ, fentanyl, acetic acid, vitamin B12, methylcobalamin, self-injection, iontophoresis

Related Categories: FORMULATIONS, PARENTERALS, TECHNOLOGY

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Jet Injection Devices for the Needle-free Administration of Compounds, Vaccines, and Other Agents
Logomasini Mark A
, Stout Richard R, Ron Marcinkoski
Jul/Aug 2013
Pg. 270-280

Intravenous Needle-free Injection Devices: New Information for Compounding Pharmacists
Macklin Denise
, Blackburn Paul L
Mar/Apr 2013
Pg. 100-110

Basics of Sterile Compounding: Sterile Product Packaging and Delivery Systems
Akers Michael J
Nov/Dec 2015
Pg. 491-500

Chemical Stability of Admixtures Combining Ziconotide with Fentanyl or Sufentanil During Simulated Intrathecal Administration
Shields David E
, Aclan Jennifer, Szatkowski Aaron
Sep/Oct 2008
Pg. 463-466

Stability of Aminocaproic Acid Injection Admixtures in 5% Dextrose Injection and 0.9% Sodium Chloride Injection
Zhang Yan-ping
, Trissel Lawrence A
Mar/Apr 1997
Pg. 132-134

A Needle-free Reconstitution and Transfer System for Compounded Sterile Intravenous Drug Solutions: In Compliance with United States Pharmacopeia Chapter <797> Standards
Marks Zach
Mar/Apr 2014
Pg. 94-99

Basics of Sterile Compounding: Clinical Hazards of Injectable Drug Administration
Akers Michael J
May/Jun 2016
Pg. 217-222

Dilution and Compounding of Ziconotide for Intrathecal Administration
Buchta Tony
, Fakata Keri, Stuart William
May/Jun 2008
Pg. 200-207

Compatibility and Stability of Palonosetron Hydrochloride with Four Neuromuscular Blocking Agents During Simulated Y-Site Administration
Trusley Craig
, Ben Michel, Kupiec Thomas C, Trissel Lawrence A
Mar/Apr 2008
Pg. 156-160

Physico-chemical Stability of MabThera Drug-product Solution for Subcutaneous Injection under In-use Conditions with Different Administration Materials
Mueller Claudia
, Dietel Elde, Heynen Severin R, Nalenz Heiko, Goldbach Pierre, Mahler Hanns-Christian, Schmidt Johannes, Grauschopf Ulla, Schoenhammer Karin
May/Jun 2015
Pg. 261-267

Compounding with Biotechnology Products, Part 2: Product-specific Considerations
Allen Loyd V Jr
Nov/Dec 2022
Pg. 446-466

Compatibility of Micafungin Injection with Other Drugs During Simulated Y-Site Co-administration
Trusley Craig
, Kupiec Thomas C, Trissel Lawrence A
May/Jun 2006
Pg. 230-233

Development of Clonidine HCl Injections for Epidural and Intrathecal Administration
Trissel Lawrence A
, Xu Quanyun A, Hassebusch
Jul/Aug 1997
Pg. 274-277

Compatibility of Paclitaxel Injection Diluent with Two Reduced-Phthalate Administration Sets for the Acclaim Pump
Xu Quanyun A
, Trissel Lawrence A
Sep/Oct 1998
Pg. 382-384

U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances
Miller David G
Jul/Aug 2015
Pg. 303-305

U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs
Allen Loyd V Jr
Nov/Dec 2015
Pg. 487-488

The U.S. Food and Drug Administration Responds to the International Academy of Compounding Pharmacists' Outsourcing Letter
Miller David G
May/Jun 2014
Pg. 208

Bilateral Areolar Hyperpigmentation Following Transdermal Administration of Compounded Hormone Replacement Therapy
Griffee Chris
, Delano Amy
Mar/Apr 2012
Pg. 110-114

U.S. Food and Drug Administration Inspections: Guide to a Successful Outcome for 503A Sterile Compounding Pharmacies
Yoch Doug
Mar/Apr 2017
Pg. 95-102

Basics of Compounding: Vehicle for Drug Administration via Enteral Feeding Tubes
Allen Loyd V Jr
May/Jun 2022
Pg. 214-217

Return to Top